ArticleFrontiers in medicine2026
Distal cholangiocarcinoma with rare progression to distal femoral metastasis: a case report and literature review.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cholangiocarcinoma (CCA) is a malignant neoplasm arising from the biliary epithelium and is associated with an exceptionally poor prognosis. Metastasis to long bones is particularly uncommon. A 66-year-old male patient developed femoral metastasis 2 years following a pancreaticoduodenectomy for distal cholangiocarcinoma and subsequently underwent total knee arthroplasty. He experienced a satisfactory postoperative recovery, with a marked enhancement in mobility. This case suggests that radical surgical intervention may be a viable option for metastatic bone disease characterised by isolated lesions. As illustrated in this instance, this therapeutic approach can alleviate symptoms and enhance the quality of life for the remaining duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.